Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000105

Director sold 100 shares at an average $1,059.24 ($105,924)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RYAN ARTHUR F · Director

Table I: Non-derivative

19 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-01 Sale : show line 1 in the form 10b5-1 −3 $1,047.11 $3,141 17,979 D
2024-07-01 Sale : show line 2 in the form 10b5-1 −2 $1,050.87 $2,102 17,977 D
2024-07-01 Sale : show line 3 in the form 10b5-1 −7 $1,051.58 $7,361 17,970 D
2024-07-01 Sale : show line 4 in the form 10b5-1 −6 $1,052.19 $6,313 17,964 D
2024-07-01 Sale : show line 5 in the form 10b5-1 −8 $1,053.60 $8,429 17,956 D
2024-07-01 Sale : show line 6 in the form 10b5-1 −1 $1,054.25 $1,054 17,955 D
2024-07-01 Sale : show line 7 in the form 10b5-1 −2 $1,056.81 $2,114 17,953 D
2024-07-01 Sale : show line 8 in the form 10b5-1 −2 $1,057.64 $2,115 17,951 D
Open-market sales · 100 sh · avg $1,059.24 · $105,924
Loading xslF345X05/edgardoc.xml…